AE Wealth Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$362K Buy
18,336
+1,511
+9% +$37.9K ﹤0.01% 1434
2026
Q2
$481K Buy
16,825
+1,047
+7% +$33.2K ﹤0.01% 1234
2026
Q1
$497K Sell
15,778
-227
-1% -$7.15K ﹤0.01% 1116
2025
Q4
$472K Buy
16,005
+840
+6% +$23.3K ﹤0.01% 1077
2025
Q3
$383K Buy
+15,165
New +$370K ﹤0.01% 1080

Other funds holding RTO

AE Wealth Management's RTO Position: Q3 2026 in Review

AE Wealth Management increased its Rentokil (RTO) stake by 9% in Q3 2026, buying an estimated $37.9K and bringing the position to 18,336 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #1434.

AE Wealth Management first reported a position in RTO in Q3 2025 and has held it in 5 quarters since. The position peaked at $497K in Q1 2026. 258 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • AE Wealth Management held 18,336 shares of Rentokil worth $362K as of Q3 2026.
  • AE Wealth Management bought 1,511 Rentokil shares in Q3 2026, an estimated $37.9K.
  • Rentokil made up ﹤0.01% of AE Wealth Management's portfolio in Q3 2026, its #1434 holding.
  • AE Wealth Management first reported a position in Rentokil in Q3 2025 and has held it in 5 quarters since.
  • AE Wealth Management's Rentokil position peaked at $497K in Q1 2026.
  • 258 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on AE Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.